Molecular data available for several of such tumors support their relationship with carcinoids based on the presence of MEN1 mutations (typical of carcinoids) and the absence of RB1 and TP53 alterations (typical of NECs)7,22. The gene discussed is RB1; the disease is carcinoid tumor.